Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers R > Headlines for Reckitt Benckiser Group plc > News item |
HSR wait ends for Reckitt Benckiser, Adams Respiratory merger
By Lisa Kerner
Charlotte, N.C., Jan. 7 - The acquisition of Adams Respiratory Therapeutics, Inc. by Reckitt Benckiser Group plc was granted early termination of the Hart-Scott-Rodino waiting period by the Federal Trade Commission, it was announced on Monday.
As previously reported, Reckitt Benckiser's subsidiary, Twickenham Inc., began its $60-per-share tender offer for all of the outstanding shares of Adams Respiratory.
The offer, valued at some $2.3 billion, ends Jan. 23.
Adams is a specialty pharmaceutical company based in Chester, N.J.
Reckitt Benckiser is a household cleaning, health and personal care company based in Slough, England. The company's brands include Lysol, Electrasol, Woolite, Veet and Gaviscon.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.